Advances in our understanding of the pathogenesis of Henoch-Schönlein purpura and the implications for improving its diagnosis

References

• Saulsbury FT. Henoch-Schönlein purpura. Curr. Opin. Rheumatol. 22(5), 598–602 (2010).
   PubMedGoogle Scholar
• Davin JC, Weening JJ. Henoch-Schönlein purpura nephritis: an update. Eur. J. Pediatr. 160(12), 689–695 (2001).
   PubMedGoogle Scholar
• Aalberse J, Dolman K, Ramnath G, Pereira RR, Davin JC. Henoch-Schönlein purpura in children: an epidemiological study among Dutch paediatricians on incidence and diagnostic criteria. Ann. Rheum. Dis. 66(12), 1648–1650 (2007).
   PubMedGoogle Scholar
• Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360(9341), 1197–1202 (2002).
   PubMedGoogle Scholar
• Weiss PF, Klink AJ. Luan X, Feudtner C. Temporal association of Streptococcus, Staphylococcus, and parainfluenza pediatric hospitalizations and hospitalized cases of Henoch-Schönlein purpura. J. Rheumatol. 37(12), 2587–2594 (2010).
   PubMedGoogle Scholar
• Farley TA. Gillespie S, Rasoulpour M, Tolentino N, Hadler JL, Hurwitz E. Epidemiology of a cluster of Henoch-Schönlein purpura. Am. J. Dis. Child. 143(7), 798–803 (1989).
   PubMedGoogle Scholar
• Borras-Blasco J, Enriquez R, Amoros F et al. Henoch-Schönlein purpura associated with clarithromycin. Case report and review of literature. Int. J. Clin. Pharmacol. Ther. 41(5), 213–216 (2003).
   PubMedGoogle Scholar
• Spyridis N. Salapata M, Fessatou S, Kontaxaki C, Spyridis P. Simultaneous presentation of Henoch-Schönlein purpura in monozygotic twins. Scand. J. Infect. Dis. 37(9), 703–704 (2005).
   PubMedGoogle Scholar
• Motoyama O. Iitaka K. Familial cases of Henoch-Schönlein purpura in eight families. Pediatr. Int. 47(6), 612–615 (2005).
   PubMedGoogle Scholar
• Shin JI, Lee JS. Familial clusturing of Henoch-Schönlein purpura or IgA nephropathy: genetic background or environmental triggers? Pediatr. Dermatol. 25(6), 651 (2008).
   PubMedGoogle Scholar
• Zhang Y. Gu W, Mao J. Sibling cases of Henoch-Schönlein purpura in two families and review of literature. Pediatr. Dermatol. 25(3), 393–395 (2008).
   PubMedGoogle Scholar
• Soylemezoglu O. Peru H, Gonen S, Cetinyurek A, Buyan N. HLA-DRB1 alleles and Henoch-Schönlein purpura: susceptibility and severity of disease. J. Rheumatol. 35(6), 1165–1168 (2008).
   PubMedGoogle Scholar
• Soylemezoglu O, Peru H, Gonen S et al. CTLA-4 +49 A/G genotype and HLA-DRB1 polymorphisms in Turkish patients with Henoch-Schönlein purpura. Pediatr. Nephrol. 23(8), 1239–1244 (2008).
   PubMedGoogle Scholar
• Amoli MM, Thomson W, Hajeer AH et al. HLA-B35 association with nephritis in Henoch-Schönlein purpura. J. Rheumatol. 29(5), 948–949 (2002).
   PubMedGoogle Scholar
• Jin DK. Kohsaka T, Koo JW, Ha IS, Cheong HI, Choi Y. Complement 4 locus II gene deletion and DQA1*0301 gene: genetic risk factors for IgA nephropathy and Henoch-Schönlein nephritis. Nephron 73(3), 390–395 (1996).
   PubMedGoogle Scholar
• Ren SM, Yang GL, Liu CZ et al. Association between HLA-A and -B polymorphisms and susceptibility to Henoch-Schönlein purpura in Han and Mongolian children from Inner Mongolia. Genet. Mol. Res. 11(1), 221–228 (2012).
   PubMedGoogle Scholar
• Reiser J. Mundel P. Dual effects of RAS blockade on blood pressure and podocyte function. Curr. Hypertens. Rep. 9(5), 403–408 (2007).
   PubMedGoogle Scholar
• Ozkaya O, Soylemezoglu O, Gonen S et al. Renin-angiotensin system gene polymorphisms: association with susceptibility to Henoch-Schönlein purpura and renal involvement. Clin. Rheumatol. 25(6), 861–865 (2006).
   PubMedGoogle Scholar
• Zhou TB. Ou C, Qin YH, Luo W. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and Henoch-Schönlein purpura nephritis risk in Asian children. Clin. Exp. Rheumatol. 30(2), 315–316 (2012).
   PubMedGoogle Scholar
• Torres O. Palomino-Morales R, Miranda-Filloy JA,Vazquez-RodriguezTR, Martin J, Gonzalez-Gay MA. IL-18 gene polymorphisms in Henoch-Schönlein purpura. Clin. Exp. Rheumatol. 28(1 Suppl. 57), 114 (2010).
   PubMedGoogle Scholar
• Yang YH, Lai HJ, Kao CK, Lin YT, Chiang BL. The association between transforming growth factor-beta gene promoter C-509T polymorphism and Chinese children with Henoch-Schönlein purpura. Pediatr. Nephrol. 19(9), 972–975 (2004).
   PubMedGoogle Scholar
• Nikibakhsh AA, Houshmand M, Bagheri M, Zadeh HM, Rad IA. MEFV gene mutations (M694V, V726A, M680I, and A744S) in Iranian children with Henoch-Schönlein purpura. Pneumologia 61(2), 84–87 (2012).
   PubMedGoogle Scholar
• Ozcakar ZB, Yalcinkaya F, Cakar N et al. MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura. J. Rheumatol. 35(12), 2427–2429 (2008).
   PubMedGoogle Scholar
• He X, Lu H, Kang S et al. MEFV E148Q polymorphism is associated with Henoch-Schönlein purpura in Chinese children. Pediatr. Nephrol. 25(10), 2077–2082 (2010).
   PubMedGoogle Scholar
• Amoli MM, Thomson W, Hajeer AH et al. Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. J. Rheumatol. 29(7), 1404–1407 (2002).
   PubMedGoogle Scholar
• Tabel Y. Mir S, Berdeli A. Interleukin 8 gene 2767 A/G polymorphism is associated with increased risk of nephritis in children with Henoch-Schönlein purpura. Rheumatol. Int. 32(4), 941–947 (2012).
   PubMedGoogle Scholar
• Amoli MM, Calvino MC. Garcia-Porrua C, Llorca J, Ollier WE, Gonzalez-Gay MA. Interleukin 1beta gene polymorphism association with severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. J. Rheumatol. 31(2), 295–298 (2004).
   PubMedGoogle Scholar
• Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc. Natl Acad. Sci. USA 92(16), 7450–7454 (1995).
   PubMedGoogle Scholar
• Li J. Liu H. P-selectin gene -825 polymorphism is associated with risk of Henoch-Schönlein purpura nephritis. Clin. Exp. Rheumatol. 29(1 Suppl. 64), S134 (2011).
   PubMedGoogle Scholar
• Amoli MM, Mattey DL, Calvino MC et al. Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Schönlein purpura. J. Rheumatol. 28(5), 1014–1018 (2001).
   PubMedGoogle Scholar
• Wang JJ, Shi YP, Yue H, Chun W, Zou LP. CTLA-4 exon 1 +49A/G polymorphism is associated with renal involvement in pediatric Henoch-Schönlein purpura. Pediatr. Nephrol. 27(11), 2059–2064 (2012).
   PubMedGoogle Scholar
• Martin J, Paco L, Ruiz MP et al. Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain. J. Rheumatol. 32(6), 1081–1085 (2005).
   PubMedGoogle Scholar
• Torres O. Palomino-Morales R, Miranda-Filloy JA, Vazquez-Rodriguez TR,Martin J, Gonzalez-Gay MA. Lack of association between toll-like receptor 4 gene polymorphism and Henoch-Schönlein purpura. Clin. Exp. Rheumatol. 28(1 Suppl. 57), 110 (2010).
   PubMedGoogle Scholar
• Soylu A, Kizildag S, Kavukcu S et al. TLR-2 Arg753Gln, TLR-4 Asp299Gly, and TLR-4 Thr399Ile polymorphisms in Henoch-Schönlein purpura with and without renal involvement. Rheumatol. Int. 30(5), 667–670 (2010).
   PubMedGoogle Scholar
• Kiryluk K, Moldoveanu Z, Sanders JT et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int. 80(1), 79–87 (2011).
   PubMed Web of Science ®Google Scholar
• He X, Zhao P, Kang S et al. C1GALT1 polymorphisms are associated with Henoch-Schönlein purpura nephritis. Pediatr. Nephrol. 27(9), 1505–1509 (2012).
   PubMedGoogle Scholar
• Davin JC, Ten Berge IJ, Weening JJ What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int. 59(3), 823–834 (2001).
   PubMedGoogle Scholar
• Kondo N, Kasahara K, Shinoda S, Orii T. Accelerated expression of secreted alpha-chain gene in anaphylactoid purpura. J. Clin. Immunol. 12(3), 193–196 (1992).
   PubMedGoogle Scholar
• De Almeida JL, Campos LM, Paim LB, Leone C, Koch VH, Silva CA. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of initial prognostic factors. J. Pediatr. (Rio J.) 83(3), 259–266 (2007).
   PubMedGoogle Scholar
• Shin JI, Park JM, Shin YH, Lee JS, Jeong HJ, Kim HS. Serum IgA/C3 ratio may be a useful marker of disease activity in severe Henoch-Schönlein nephritis. Nephron Clin. Pract. 101(2), c72–c78 (2005).
   PubMedGoogle Scholar
• Yoo EM, Morrison SL. IgA: an immune glycoprotein. Clin. Immunol. 116(1), 3–10 (2005).
   PubMedGoogle Scholar
• Kerr MA. The structure and function of human IgA. Biochem. J. 271(2), 285–296 (1990).
   PubMed Web of Science ®Google Scholar
• Renfrow MB, Mackay CL, Chalmers MJ et al. Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy. Anal. Bioanal. Chem. 389(5), 1397–1407 (2007).
   PubMedGoogle Scholar
• Field MC, Dwek RA, Edge CJ, Rademacher TW. O-linked oligosaccharides from human serum immunoglobulin A1. Biochem. Soc. Trans. 17(6), 1034–1035 (1989).
   PubMedGoogle Scholar
• Allen AC, Willis FR, Beattie TJ. Feehally J. Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol. Dial. Transplant. 13(4), 930–934 (1998).
   PubMedGoogle Scholar
• Szer IS, Pierce H. Henoch-Schönlein purpura. In: Rheumatology (Oxford). HochbergMC (Ed.). Mosby/Elsevier, Philadelphia, PA, USA, 1587–1596.e1582 (2011).
   Google Scholar
• Moore JS, Kulhavy R, Tomana M et al. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. Mol. Immunol. 44(10), 2598–2604 (2007).
   PubMedGoogle Scholar
• Lau KK, Wyatt RJ, Moldoveanu Z et al. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr. Nephrol. 22(12), 2067–2072 (2007).
   PubMedGoogle Scholar
• Davin JC, Pierard G, Dechenne C et al. Possible pathogenic role of IgE in Henoch-Schönlein purpura. Pediatr. Nephrol. 8(2), 169–171 (1994).
   PubMedGoogle Scholar
• He X, Li Y, Kang S et al. The CD18 AvaII polymorphic site not associated with Henoch-Schönlein purpura. Clin. Exp. Rheumatol. 29(1 Suppl. 64), S117–S120 (2011).
   PubMedGoogle Scholar
• Zhang GP, Dang XQ, Yi ZW et al. Role, of mast cells in the development of renal interstitial fibrosis in children with Henoch-Schönlein purpura nephritis. Zhongguo Dang Dai Er Ke Za Zhi 9(2), 125–128 (2007).
   PubMedGoogle Scholar
• Namgoong MK, Lim BK, Kim JS. Eosinophil cationic protein in Henoch-Schönlein purpura and in IgA nephropathy. Pediatr. Nephrol. 11(6), 703–706 (1997).
   PubMedGoogle Scholar
• Kawasaki Y, Hosoya M, Suzuki H. Possible pathologenic role of interleukin-5 and eosino cationic protein in Henoch-Schönlein purpura nephritis. Pediatr. Int. 47(5), 512–517 (2005).
   PubMedGoogle Scholar
• Chen Y, Zhou JH, Wu HS, Wang HW. Role of mast cells and eosinophil cationic protein in the pathogenesis of Henoch-Schönlein purpura nephritis. Zhonghua Er Ke Za Zhi 44(6), 407–410 (2006).
   PubMedGoogle Scholar
• Faille-Kuyber EH, Kater L, Kooiker CJ, Dorhout Mees EJ. IgA-deposits in cutaneous blood-vessel walls and mesangium in Henoch-Schönlein syndrome. Lancet 1(7808), 892–893 (1973).
   PubMedGoogle Scholar
• Shulman ST, Barratt TM, Soothill JF. Immunoconglutinin and complement studies in congenital nephrotic syndrome and nephritis of Henoch-Schönlein purpura in children. Arch. Dis. Child. 46(250), 838–841 (1971).
   PubMedGoogle Scholar
• Evans DJ, Williams DG, Peters DK et al. Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br. Med. J. 3(5875), 326–328 (1973).
   PubMedGoogle Scholar
• Smith MD, Barratt TM, Hayward AR, Soothill JF. The inhibition of complement-dependent lymphocyte rosette formation by the sera of children with steroid-sensitive nephrotic syndrome and other renal diseases. Clin. Exp. Immunol. 21(2), 236–243 (1975).
   PubMedGoogle Scholar
• Lawrence S, Pussell BA, Charlesworth JA. Mesangial IgA nephropathy: detection of defective reticulophagocytic function in vivo. Clin. Nephrol. 19(6), 280–283 (1983).
   PubMedGoogle Scholar
• Waldo FB. Is Henoch-Schönlein purpura the systemic form of IgA nephropathy. Am. J. Kidney Dis. 12(5), 373–377 (1988).
   PubMedGoogle Scholar
• Ault BH, Stapleton FB, Rivas ML et al. Association of Henoch-Schönlein purpura glomerulonephritis with C4B deficiency. J. Pediatr. 117(5), 753–755 (1990).
   PubMedGoogle Scholar
• Mclean RH, Wyatt RJ, Julian BA. Complement phenotypes in glomerulonephritis: increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpura. Kidney Int. 26(6), 855–860 (1984).
   PubMedGoogle Scholar
• Kawana S, Shen GH, Kobayashi Y, Nishiyama S. Membrane attack complex of complement in Henoch-Schönlein purpura skin and nephritis. Arch. Dermatol. Res. 282(3), 183–187 (1990).
   PubMedGoogle Scholar
• Bussolati B, Peri G, Salvidio G, Verzola D, Mantovani A, Camussi G. The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells. J. Immunol. 170(3), 1466–1472 (2003).
   PubMedGoogle Scholar
• Nauta AJ, Bottazzi B, Mantovani A et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur. J. Immunol. 33(2), 465–473 (2003).
   PubMedGoogle Scholar
• Spitzer RE, Urmson JR, Farnett ML, Stitzel AE, Post EM. Alteration of the complement system in children with Henoch-Schönlein purpura. Clin. Immunol. Immunopathol. 11(1), 52–59 (1978).
   PubMedGoogle Scholar
• Garcia-Fuentes M, Martin A, Chantler C, Williams DG. Serum complement components in Henoch-Schönlein purpura. Arch. Dis. Child. 53(5), 417–419 (1978).
   PubMedGoogle Scholar
• Levy M, Gonzalez-Burchard G, Broyer M et al. Berger’s disease in children. Natural history and outcome. Medicine (Baltimore) 64(3), 157–180 (1985).
   PubMedGoogle Scholar
• Smith GC, Davidson JE, Hughes DA, Holme E, Beattie TJ. Complement activation in Henoch-Schönlein purpura. Pediatr. Nephrol. 11(4), 477–480 (1997).
   PubMedGoogle Scholar
• Davin JC, Vandenbroeck MC, Foidart JB, Mahieu PR. Sequential measurements of the reticulo-endothelial system function in Henoch-Schönlein disease of childhood. Correlations with various immunological parameters. Acta Paediatr. Scand. 74(2), 201–206 (1985).
   PubMedGoogle Scholar
• Endo Y. IgA nephropathy--human disease and animal model. Ren. Fail. 19(3), 347–371 (1997).
   PubMedGoogle Scholar
• Hisano S, Matsushita M, Fujita T, Iwasaki H. Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis. Am. J. Kidney Dis. 45(2), 295–302 (2005).
   PubMedGoogle Scholar
• Thiel S, Vorup-Jensen T, Stover CM et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386(6624), 506–510 (1997).
   PubMedGoogle Scholar
• Stover CM, Thiel S, Thelen M et al. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J. Immunol. 162(6), 3481–3490 (1999).
   PubMedGoogle Scholar
• Matsushita M, Fujita T. Ficolins and the lectin complement pathway. Immunol. Rev. 180, 78–85 (2001).
   PubMedGoogle Scholar
• Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today 17(11), 532–540 (1996).
   PubMedGoogle Scholar
• Ogura Y, Suzuki S, Shirakawa T et al. Haemophilus parainfluenzae antigen and antibody in children with IgA nephropathy and Henoch-Schönlein nephritis. Am. J. Kidney Dis. 36(1), 47–52 (2000).
   PubMedGoogle Scholar
• Roos A, Bouwman LH, Van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 167(5), 2861–2868 (2001).
   PubMedGoogle Scholar
• Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M. Complement activation through the lectin pathway in patients with Henoch-Schönlein purpura nephritis. Am. J. Kidney Dis. 35(3), 401–407 (2000).
   PubMedGoogle Scholar
• Abou-Ragheb HH, Williams AJ, Brown CB. Milford-Ward A. Plasma levels of the anaphylatoxins C3a and C4a in patients with IgA nephropathy/ Henoch-Schönlein nephritis. Nephron 62(1), 22–26 (1992).
   PubMedGoogle Scholar
• Stefansson Thors V, Kolka R, Sigurdardottir SL, Edvardsson VO, Arason G, Haraldsson A. Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. Scand. J. Immunol. 61(3), 274–278 (2005).
   PubMedGoogle Scholar
• Islek I, Muslu A, Dagdemir A, Dilber C. Is low serum complement 3 in Henoch-Schönlein purpura unusual and of prognostic value. Eur. J. Pediatr. 160(6), 397–398 (2001).
   PubMedGoogle Scholar
• Zwirner J, Burg M, Schulze M et al. Activated complement C3: a potentially novel predictor of progressive IgA nephropathy. Kidney Int. 51(4), 1257–1264 (1997).
   PubMedGoogle Scholar
• Kawana S, Nishiyama S. Serum SC5b-9 (terminal complement complex) level, a sensitive indicator of disease activity in patients with Henoch-Schönlein purpura. Dermatology 184(3), 171–176 (1992).
   PubMedGoogle Scholar
• Kusunoki Y, Akutsu Y, Itami N et al. Urinary excretion of terminal complement complexes in glomerular disease. Nephron 59(1), 27–32 (1991).
   PubMedGoogle Scholar
• Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8(4), 345–350 (2007).
   PubMedGoogle Scholar
• Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 21(4), 467–476 (2004).
   PubMedGoogle Scholar
• Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14(2), 155–174 (2003).
   PubMedGoogle Scholar
• Khoury SJ. Th17 and Treg balance in systemic sclerosis. Clin. Immunol. 139(3), 231–232 (2011).
   PubMedGoogle Scholar
• Ziegler SF. FOXP3: not just for regulatory T cells anymore. Eur. J. Immunol. 37(1), 21–23 (2007).
   PubMedGoogle Scholar
• Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117(3), 289–300 (2006).
   PubMedGoogle Scholar
• Chen O, Zhu XB, Ren H, Wang YB, Sun R. The imbalance of Th17/Treg in Chinese children with Henoch-Schönlein purpura. Int. Immunopharmacol. 16(1), 67–71 (2013).
   PubMedGoogle Scholar
• Li YY, Li CR, Wang GB, Yang J, Zu Y. Investigation of the change in CD4(+) T cell subset in children with Henoch-Schönlein purpura. Rheumatol. Int. 32(12), 3785–3792 (2012).
   PubMedGoogle Scholar
• Jen HY, Chuang YH, Lin SC, Chiang BL, Yang YH. Increased serum interleukin-17 and peripheral Th17 cells in children with acute Henoch-Schönlein purpura. Pediatr. Allergy Immunol. 22(8), 862–868 (2011).
   PubMedGoogle Scholar
• Besbas N, Saatci U, Ruacan S et al. The role of cytokines in Henoch-Schönlein purpura. Scand. J. Rheumatol. 26(6), 456–460 (1997).
   PubMedGoogle Scholar
• Yang YH, Lai HJ, Huang CM, Wang LC, Lin YT, Chiang BL. Sera from children with active Henoch-Schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells. Ann. Rheum. Dis. 63(11), 1511–1513 (2004).
   PubMedGoogle Scholar
• Wu TH, Wu SC, Huang TP, Yu CL, Tsai CY. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura. Nephron 74(1), 79–88 (1996).
   PubMedGoogle Scholar
• Lin CY, Yang YH, Lee CC, Huang CL, Wang LC, Chiang BL. Thrombopoietin and interleukin-6 levels in Henoch-Schönlein purpura. J. Microbiol. Immunol. Infect. 39(6), 476–482 (2006).
   PubMedGoogle Scholar
• Yang YH, Chuang YH, Wang LC, Huang HY, Gershwin ME, Chiang BL. The immunobiology of Henoch-Schönlein purpura. Autoimmun. Rev. 7(3), 179–184 (2008).
   PubMedGoogle Scholar
• Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 84(7), 2068–2101 (1994).
   PubMedGoogle Scholar
• Rostoker G, Rymer JC, Bagnard G, Petit-Phar M, Griuncelli M, Pilatte Y. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?Clin. Exp. Immunol. 114(3), 468–476 (1998).
   PubMedGoogle Scholar
• Wu L, Yuan LP, Fei WJ et al. Impact of sera from children with active Henoch-Schönlein purpura on human umbilical venous endothelial cells (HUVECs) and protective effects of methylprednisolone against HUVECs injury. Zhongguo Dang Dai Er Ke Za Zhi 14(1), 59–63 (2012).
   PubMedGoogle Scholar
• Yang YH, Huang YH, Lin YL et al. Circulating IgA from acute stage of childhood Henoch-Schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway. Clin. Exp. Immunol. 144(2), 247–253 (2006).
   PubMedGoogle Scholar
• Takemura T, Yoshioka K, Murakami K et al. Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch. 424(5), 459–464 (1994).
   PubMedGoogle Scholar
• Gattorno M, Vignola S, Barbano G et al. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus. J. Rheumatol. 27(9), 2251–2255 (2000).
   PubMedGoogle Scholar
• Gok F, Ugur Y, Ozen S, Dagdeviren A. Pathogenesis-related adhesion molecules in Henoch-Schönlein vasculitis. Rheumatol. Int. 28(4), 313–316 (2008).
   PubMedGoogle Scholar
• Chen T, Guo ZP, Li MM et al. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schönlein purpura. Clin. Exp. Immunol. 166(1), 64–71 (2011).
   PubMedGoogle Scholar
• Topaloglu R, Sungur A, Baskin E, Besbas N, Saatci U, Bakkaloglu A. Vascular endothelial growth factor in Henoch-Schönlein purpura. J. Rheumatol. 28(10), 2269–2273 (2001).
   PubMedGoogle Scholar
• Yao JS, Zhai W, Young WL, Yang GY. Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9. Biochem. Biophys. Res. Commun. 342(4), 1396–1404 (2006).
   PubMedGoogle Scholar
• Mahajan N, Bisht D, Dhawan V, Singh S, Minz RW. Transcriptional expression and gelatinolytic activity of matrix metalloproteinases in Henoch-Schönlein purpura. Acta Paediatr. 99(8), 1248–1252 (2010).
   PubMedGoogle Scholar
• Shin JI, Song KS, Kim H et al. The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura. Br. J. Dermatol. 164(6), 1348–1355 (2011).
   PubMedGoogle Scholar
• Bertani T, Abbate M, Zoja C et al. Tumor necrosis factor induces glomerular damage in the rabbit. Am. J. Pathol. 134(2), 419–430 (1989).
   PubMedGoogle Scholar
• Kawasaki Y, Suzuki J, Sakai N et al. Evaluation of T helper-1/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis. Am. J. Kidney Dis. 44(1), 42–49 (2004).
   PubMedGoogle Scholar
• Sun DQ, Zhang QY, Dong ZY, Bai F. Levels of IL-12 produced by dendritic cells and changes of TH1/TH2 balance in children with Henoch-Schönlein purpura. Zhongguo Dang Dai Er Ke Za Zhi 8(4), 307–310 (2006).
   PubMedGoogle Scholar
• Tahan F, Dursun I, Poyrazoglu H, Gurgoze M, Dusunsel R. The role of chemokines in Henoch-Schönlein purpura. Rheumatol. Int. 27(10), 955–960 (2007).
   PubMedGoogle Scholar
• De Mattia D, Penza R, Giordano P et al. von Willebrand factor and factor XIII in children with Henoch-Schönlein purpura. Pediatr. Nephrol. 9(5), 603–605 (1995).
   PubMedGoogle Scholar
• Soylemezoglu O, Sultan N, Gursel T, Buyan N, Hasanoglu E. Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in Henoch-Schönlein purpura. Arch. Dis. Child. 75(6), 507–511 (1996).
   PubMedGoogle Scholar
• Del Vecchio GC, Penza R, Altomare M et al. Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura. Immunopharmacol. Immunotoxicol. 30(3), 623–629 (2008).
   PubMedGoogle Scholar
• Brendel-Muller K, Hahn A, Schneppenheim R, Santer R. Laboratory signs of activated coagulation are common in Henoch-Schönlein purpura. Pediatr. Nephrol. 16(12), 1084–1088 (2001).
   PubMedGoogle Scholar
• Yilmaz D, Kavakli K, Ozkayin N. The elevated markers of hypercoagulability in children with Henoch-Schönlein purpura. Pediatr. Hematol. Oncol. 22(1), 41–48 (2005).
   PubMedGoogle Scholar
• Topaloglu R, Bayrakci US, Cil B, Orhon D, Bakkaloglu A. Henoch-Schönlein purpura with high factor VIII levels and deep venous thrombosis: an association or coincidence?Rheumatol. Int. 28(9), 935–937 (2008).
   PubMedGoogle Scholar
• Imai T, Okada H, Nanba M, Kawada K, Kusaka T, Itoh S. Henoch-Schönlein purpura with intracerebral hemorrhage. Brain Dev. 24(2), 115–117 (2002).
   PubMedGoogle Scholar
• Culic S, Jakl R, Metlicic V et al. Platelet function analysis in children with Schönlein-Henoch syndrome. Arch. Med. Res. 32(4), 268–272 (2001).
   PubMedGoogle Scholar
• Knight JF. The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schonlein purpura. Pediatr. Nephrol. 4(5), 533–541 (1990).
   PubMedGoogle Scholar
• Harris EN, Gharavi AE, Hughes GR. Anti-phospholipid antibodies. Clin. Rheum. Dis. 11(3), 591–609 (1985).
   PubMedGoogle Scholar
• Ravelli A, Martini A. Antiphospholipid syndrome. Pediatr. Clin. North Am 52(2), 469–491; vi (2005).
   PubMedGoogle Scholar
• Matsuura E, Igarashi Y, Fujimoto M et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J. Immunol. 148(12), 3885–3891 (1992).
   PubMedGoogle Scholar
• Sokol DK, Mcintyre JA, Short RA et al. Henoch-Schönlein purpura and stroke: antiphosphatidylethanolamine antibody in CSF and serum. Neurology 55(9), 1379–1381 (2000).
   PubMedGoogle Scholar
• Abend NS, Licht DJ, Spencer CH. Lupus anticoagulant and thrombosis following Henoch-Schönlein purpura. Pediatr. Neurol. 36(5), 345–347 (2007).
   PubMedGoogle Scholar
• Shin JI, Lee JS, Kim HS. Lupus anticoagulant and IgM anti-phospholipid antibodies in Korean children with Henoch-Schönlein purpura. Scand. J. Rheumatol. 38(1), 73–74 (2009).
   PubMedGoogle Scholar
• Monastiri K, Selmi H, Tabarki B, Yacoub M, Mahjoub T, Essoussi AS. Primary antiphospholipid syndrome presenting as complicated Henoch-Schönlein purpura. Arch. Dis. Child. 86(2), 132–133 (2002).
   PubMedGoogle Scholar
• Liu A, Zhang H. Detection of antiphospholipid antibody in children with Henoch-Schönlein purpura and central nervous system involvement. Pediatr. Neurol. 47(3), 167–170 (2012).
   PubMedGoogle Scholar
• Zhang H, Huang J. Henoch-Schönlein purpura associated with antiphospholipid syndrome. Pediatr. Nephrol. 25(2), 377–378 (2010).
   PubMedGoogle Scholar
• Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis. Arthritis Rheum. 59(4), 561–567 (2008).
   PubMedGoogle Scholar
• Yang YH, Huang MT, Lin SC, Lin YT, Tsai MJ, Chiang BL. Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura. Clin. Exp. Immunol. 122(2), 285–290 (2000).
   PubMedGoogle Scholar
• Ozaltin F, Bakkaloglu A, Ozen S et al. The significance of IgA class of antineutrophil cytoplasmic antibodies (ANCA) in childhood Henoch-Schönlein purpura. Clin. Rheumatol. 23(5), 426–429 (2004).
   PubMedGoogle Scholar
• Sinico RA, Tadros M, Radice A et al. Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy. Clin. Immunol. Immunopathol. 73(1), 19–26 (1994).
   PubMedGoogle Scholar
• Robson WL, Leung AK, Woodman RC. The absence of anti-neutrophil cytoplasmic antibodies in patients with Henoch-Schönlein purpura. Pediatr. Nephrol. 8(3), 295–298 (1994).
   PubMedGoogle Scholar
• Saulsbury FT. Heavy and light chain composition of serum IgA and IgA rheumatoid factor in Henoch-Schonlein purpura. Arthritis Rheum. 35(11), 1377–1380 (1992).
   PubMedGoogle Scholar
• Saulsbury FT, Pearl ER. Cold reacting antinuclear antibody in Henoch-Schönlein purpura. J. Clin. Lab. Immunol. 12(3), 123–127 (1983).
   PubMedGoogle Scholar
• Mills JA, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum. 33(8), 1114–1121 (1990).
   PubMedGoogle Scholar
• Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 33(8), 1065–1067 (1990).
   PubMedGoogle Scholar
• Ozen S, Ruperto N, Dillon MJ et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann. Rheum. Dis. 65(7), 936–941 (2006).
   PubMedGoogle Scholar
• Ozen S, Pistorio A, Iusan SM et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann. Rheum. Dis. 69(5), 798–806 (2010).
   PubMedGoogle Scholar
• Sohagia AB, Gunturu SG, Tong TR, Hertan HI. Henoch-Schönlein purpura-a case report and review of the literature. Gastroenterol. Res. Pract. 2010, 597648 (2010).
   PubMedGoogle Scholar
• Kawakami T. New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis. J. Dermatol. 37(2), 113–124 (2010).
   PubMedGoogle Scholar
• Linskey KR, Kroshinsky D, Mihm MC Jr, Hoang MP. Immunoglobulin-A--associated small-vessel vasculitis: a 10-year experience at the Massachusetts General Hospital. J. Am. Acad. Dermatol. 66(5), 813–822 (2012).
   PubMedGoogle Scholar
• Davin JC, Weening JJ. Diagnosis of Henoch-Schönlein purpura: renal or skin biopsy?Pediatr. Nephrol. 18(12), 1201–1203 (2003).
   PubMedGoogle Scholar
• Van Hale HM, Gibson LE, Schroeter AL. Henoch-Schönlein vasculitis: direct immunofluorescence study of uninvolved skin. J. Am. Acad. Dermatol. 15(4 Pt 1), 665–670 (1986).
   PubMedGoogle Scholar
• Nagasaka T, Miyamoto J, Ishibashi M, Chen KR. MPO-ANCA- and IgA-positive systemic vasculitis: a possibly overlapping syndrome of microscopic polyangiitis and Henoch-Schönlein purpura. J. Cutan. Pathol. 36(8), 871–877 (2009).
   PubMedGoogle Scholar
• Watanabe K, Abe H, Mishima T, Ogura G, Suzuki T. Polyangitis overlap syndrome: a fatal case combined with adult Henoch-Schönlein purpura and polyarteritis nodosa. Pathol. Int. 53(8), 569–573 (2003).
   PubMedGoogle Scholar
• Akimoto S, Ishikawa O, Tsukada Y, Yano S, Miyachi Y. Microscopic polyangiitis mimicking Henoch-Schönlein purpura followed by severe renal involvement: a diagnostic role for antineutrophil cytoplasmic autoantibody. Br. J. Dermatol. 136(2), 298–299 (1997).
   PubMedGoogle Scholar
• Park CK, Ko YH, Park MH, Lee JD, Lee CW. Polyangiitis overlap syndrome: cutaneous leukocytoclastic vasculitis associated with polyarteritis nodosa. J. Korean Med. Sci. 9(3), 243–247 (1994).
   PubMedGoogle Scholar
• Yokose T, Aida J, Ito Y, Ogura M, Nakagawa S, Nagai T. A case of pulmonary hemorrhage in Henoch-Schönlein purpura accompanied by polyarteritis nodosa in an elderly man. Respiration 60(5), 307–310 (1993).
   PubMedGoogle Scholar
• Shin JI, Lee JS. Multiorgan involvement of vasculitis: Henoch-Schönlein purpura alone or polyangiitis overlap syndrome. Kidney Int. 74(6), 828 (2008).
   PubMedGoogle Scholar
• Leung AK, Robson WL. Hemorrhagic bullous lesions in a child with Henoch-Schönlein purpura. Pediatr. Dermatol. 23(2), 139–141 (2006).
   PubMedGoogle Scholar
• Trapani S, Mariotti P, Resti M, Nappini L, De Martino M, Falcini F. Severe hemorrhagic bullous lesions in Henoch-Schönlein purpura: three pediatric cases and review of the literature. Rheumatol. Int. 30(10), 1355–1359 (2010).
   PubMedGoogle Scholar
• Ishii Y, Takizawa T, Arakawa H et al. Hemorrhagic bullous lesions in Henoch-Schönlein purpura. Pediatr. Int. 47(6), 694–697 (2005).
   PubMedGoogle Scholar
• Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am. J. Clin. Dermatol. 9(2), 71–92 (2008).
   PubMedGoogle Scholar
• Tizard EJ, Hamilton-Ayres MJ. Henoch-Schönlein purpura. Arch. Dis. Child. Educ. Pract. Ed. 93(1), 1–8 (2008).
   PubMedGoogle Scholar
• Tsolia MN, Fretzayas A, Georgouli H et al. Invasive meningococcal disease presenting as Henoch-Schönlein purpura. Eur. J. Clin. Microbiol. Infect. Dis. 23(10), 776–779 (2004).
   PubMedGoogle Scholar
• Al-Attrach I, Al-Shibli A, Al-Riyami L, Al-Salam S. Systemic lupus erythematosus with severe nephritis that mimicked Henoch-Schönlein purpura. Arab. J. Nephrol. Transplant. 4(3), 159–161 (2011).
   PubMedGoogle Scholar
• Soylu A, Kavukcu S, Uzuner N, Olgac N, Karaman O, Ozer E. Systemic lupus erythematosus presenting with normocomplementemic urticarial vasculitis in a 4-year-old girl. Pediatr. Int. 43(4), 420–422 (2001).
   PubMedGoogle Scholar
• Saulsbury FT, Hart MH. Crohn’s disease presenting with Henoch-Schönlein purpura. J. Pediatr. Gastroenterol. Nutr. 31(2), 173–175 (2000).
   PubMedGoogle Scholar
• Cheungpasitporn W, Jirajariyavej T, Howarth CB, Rosen RM. Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report. J. Med. Case Rep. 5, 364 (2011).
   Google Scholar
• Chang WL, Yang YH, Lin YT, Chiang BL. Gastrointestinal manifestations in Henoch-Schönlein purpura: a review of 261 patients. Acta Paediatr. 93(11), 1427–1431 (2004).
   PubMedGoogle Scholar
• Zhang Y, Huang X. Gastrointestinal involvement in Henoch-Schönlein purpura. Scand. J. Gastroenterol. 43(9), 1038–1043 (2008).
   PubMedGoogle Scholar
• Jasic M, Subat-Dezulovic M, Nikolic H, Jonjic N, Manestar K, Dezulovic M. Henoch-Schönlein purpura complicated by appendicitis, intussusception and ureteritis. Coll. Antropol. 35(1), 197–201 (2011).
   PubMedGoogle Scholar
• Abebe M, Patnaik A, Miller F et al. Intestinal infarction and portal vein thrombosis in a patient with Henoch-Schönlein purpura. Case Rep. Rheumatol. 2012, 672959 (2012).
   PubMedGoogle Scholar
• Miniter U, Bae-Harboe YS, Powers JG, Campbell SM, Goldberg LJ. Fatal Henoch-Schönlein purpura in an adult related to bowel perforation: report and review of the literature. Dermatol. Online J. 18(10), 9 (2012).
   PubMedGoogle Scholar
• Hashimoto A, Matsushita R, Iizuka N et al. Henoch-Schönlein purpura complicated by perforation of the gallbladder. Rheumatol. Int. 29(4), 441–443 (2009).
   PubMedGoogle Scholar
• Gow KW, Murphy JJ, 3rd, Blair GK, Magee JF, Hailey J. Multiple entero-entero fistulae: an unusual complication of Henoch-Schönlein purpura. J. Pediatr. Surg. 31(6), 809–811 (1996).
   PubMedGoogle Scholar
• Aaron S, Al-Watban L, Manca D. Scrotal involvement in an adult with Henoch-Schönlein purpura. Clin. Rheumatol. 32(Suppl. 1), S93–S95 (2013).
   PubMedGoogle Scholar
• Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Schönlein-Henoch syndrome): review with a follow-up of the renal complications. AM J. Dis. Child 99, 833–854 (1960).
   Google Scholar
• Chamberlain RS, Greenberg LW. Scrotal involvement in Henoch-Schönlein purpura: a case report and review of the literature. Pediatr. Emerg. Care 8(4), 213–215 (1992).
   PubMedGoogle Scholar
• Silva CA, Cocuzza M, Borba EF, Bonfa E. Cutting-edge issues in autoimmune orchitis. Clin. Rev. Allergy Immunol. 42(2), 256–263 (2012).
   PubMedGoogle Scholar
• Ha TS, Lee JS. Scrotal involvement in childhood Henoch-Schönlein purpura. Acta Paediatr. 96(4), 552–555 (2007).
   PubMedGoogle Scholar
• Iannetti L, Zito R, Bruschi S et al. Recent understanding on diagnosis and management of central nervous system vasculitis in children. Clin. Dev. Immunol. 2012, 698327 (2012).
   PubMedGoogle Scholar
• Chen CL, Chiou YH, Wu CY, Lai PH, Chung HM. Cerebral vasculitis in Henoch-Schönlein purpura: a case report with sequential magnetic resonance imaging changes and treated with plasmapheresis alone. Pediatr. Nephrol. 15(3–4), 276–278 (2000).
   Google Scholar
• Belman AL, Leicher CR, Moshe SL, Mezey AP. Neurologic manifestations of Schönlein-Henoch purpura: report of three cases and review of the literature. Pediatrics 75(4), 687–692 (1985).
   PubMedGoogle Scholar
• Rajagopala S, Shobha V, Devaraj U, D’souza G, Garg I. Pulmonary hemorrhage in Henoch-Schönlein purpura: case report and systematic review of the english literature. Semin. Arthritis Rheum. 42(4), 391–400 (2013).
   PubMedGoogle Scholar
• Markus HS, Clark JV. Pulmonary haemorrhage in Henoch-Schönlein purpura. Thorax 44(6), 525–526 (1989).
   PubMedGoogle Scholar
• Paller AS, Kelly K, Sethi R. Pulmonary hemorrhage: an often fatal complication of Henoch-Schönlein purpura. Pediatr. Dermatol. 14(4), 299–302 (1997).
   PubMedGoogle Scholar
• Bradley JR, Lockwood CM, Thiru S. Endothelial cell activation in patients with systemic vasculitis. QJM 87(12), 741–745 (1994).
   PubMedGoogle Scholar